Benefits and drawbacks for children with psychoactive drugs
The decision of a trained professional such as a teenager and child therapist is required for psychoactive treatment and prescribing. Symptoms, co-morbid conditions, educational histories, and psychiatric conditions must be taken into account by the doctor. Children correctly diagnosed with psychoactive substance dependency benefit from psychoactive medications that encourage them to continue in school and households, while allowing the use of natural help and involvement in community care (Wlodarczyk et al. 2012). The medications, however, are dangerous and appear to induce the reversal of the expected effect on infants. Consequently, the children under medication are condemned to a life of ill health and misery. The intention is to treat chemical imbalance caused by Bipolar disorder, depression, and ADHD. The latest evidence shows that the chemical imbalance is incorrect disease causing elements. The inappropriate use of psychoactive drugs tends to create different chemical imbalances, leading to deliberating and long-life mental disorders. The use of Selective Serotonin reuptake inhibitors (SSRI’s) Paxil and Zoloft cause serious damage (Wlodarczyk et al. 2012). The use of SSRI may increase the number of children suffering from the Bi-polar disease. The drug is associated with early death, diabetes, and morbid obesity among children.
Risk and benefit of not using drugs due to improper diagnoses
Mental disorder identification in children is very difficult for healthcare practitioners. The children may differ in their mental, physical, and emotional changes in their natural growth and development. A doctor may fail to correctly diagnose the child with mental illness (Behnke, 2013). Therefore, the use of psychoactive drugs is beneficial. The child will be safe from drugs that cause a chemical imbalance. On the other hand, failing to use drugs may increase persistent feeling, depression, and bipolar disorder.
References
Behnke, M., Smith, V. C., Committee on Substance Abuse, & Committee on Fetus and Newborn. (January 01, 2013). Prenatal substance abuse: short- and long-term effects on the exposed fetus. Pediatrics, 131, 3, 1009-24.
Wlodarczyk, B. J., Palacios, A. M., George, T. M., & Finnell, R. H. (August 01, 2012). Antiepileptic drugs and pregnancy outcomes. American Journal of Medical Genetics Part A, 8, 2071-2090.
